Express News | Labcorp - Securitization Facility Contains Accordion to Increase Facility Limit up to $700 Mln
Express News | Labcorp - Co, Units, Entered Into a Three-Year $300 Million Accounts Receivable Securitization Facility
Labcorp Holdings Insider Sold Shares Worth $454,100, According to a Recent SEC Filing
Express News | Precisedx: Additional Participants in Round Include Labcorp, Quest Diagnostics, Genhenn Capital Venture
Express News | Precisedx: Raised $20.7 Mln in Series B Funding, Bringing Total Funding to Date to $31.5 Mln
JPMorgan Adjusts Price Target on Labcorp Holdings to $271 From $243, Maintains Overweight Rating
Express News | Labcorp : JP Morgan Raises Target Price to $271 From $243
Is Labcorp Holdings Inc. (NYSE:LH) Trading At A 47% Discount?
Argus Raises Laboratory Corp of America's Price Target to $260 From $250
Labcorp Holdings(LH.US) Officer Sells US$3.36 Million in Common Stock
Labcorp Holdings Insider Sold Shares Worth $3,359,825, According to a Recent SEC Filing
Insider Sale: CFO Glenn Eisenberg Sells 15,000 Shares of Labcorp Holdings Inc (LH)
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating
Form 144 | Labcorp Holdings(LH.US) Officer Proposes to Sell 3.36 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 15, $Labcorp Holdings(LH.US)$ Officer EISENBERG GLENN A intends to sell 15,000 shares of its common stock on Aug 15, with a total market value of approximately $3.36
Medicare's Negotiated Drug Prices Will Save Taxpayers $6 Billion in First Year, White House Says
US Drug Price Measure to Cut Costs by US$7.5b in 2026
Labcorp (LH) Gains From New Collaborations Amid FX Issues
Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.
With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.
These Stocks Held Up During the Selloff. What That Reveals About the Market.
Labcorp Holdings Insider Sold Shares Worth $2,770,552, According to a Recent SEC Filing